ID

44718

Descripción

The purpose of this Phase II study is to determine if AZD4877, an experimental drug that is a novel anti-mitotic agent (Eg5 or Kinesin Spindle Protein inhibitor that interferes with tumor cell division leading to tumor growth), can reduce tumor sizes in patients with bladder cancer see http://clinicaltrials.gov/ct2/show/study/NCT00661609

Link

http://clinicaltrials.gov/ct2/show/study/NCT00661609

Palabras clave

Versiones (4)
  1. 2011-11-21 2011-11-21 - Philipp Bruland
  2. 2014-03-27 2014-03-27 - Martin Dugas
  3. 2021-09-17 2021-09-17 -
  4. 2021-09-27 2021-09-27 - Sarah Riepenhausen
Titular de derechos de autor

AstraZeneca

Subido en

27 september 2021

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

A Phase II Study of AZD4877 (a Novel Anti-mitotic DRKS00004052

Inglés

Eligibility Bladder Cancer NCT00661609

1 formularios  
Inclusion criteria
Descripción

Inclusion criteria

Alias
UMLS CUI [1]
C1512693
Confirmed urothelial cancer (cancer of the bladder, renal pelvis, ureter, or urethra).
Descripción

Urothelial cancer

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1519840
Tumor, Node, Metastasis (TNM) Stage IV urothelial cancer that can not be helped by curative surgery and/or curative radiotherapy
Descripción

Stage IV

Tipo de datos

boolean

Alias
UMLS CUI-1
C0441772
Must have had a maximum of 2 prior chemotherapeutic regimens, one for unremovable and/or metastasized disease, and the other in the adjuvant or neo-adjuvant setting.
Descripción

Prior chemotherapy

Tipo de datos

boolean

Alias
UMLS CUI-1
C1514457
Ambulatory and capable of all selfcare more than 50% of waking hours
Descripción

Selfcare

Tipo de datos

boolean

Alias
UMLS CUI-1
C0036592
Exclusion criteria
Descripción

Exclusion criteria

Alias
UMLS CUI [1]
C0680251
Prior treatment with investigational or standard anti-cancer agents, including radiotherapy, within 4 weeks prior to first dose of study medication; 6 weeks if prior systemic mitomycin, nitrosourea, or suramin.
Descripción

Prior treatment

Tipo de datos

boolean

Alias
UMLS CUI-1
C1514463
Inadequate bone marrow reserve
Descripción

Bone marrow

Tipo de datos

boolean

Alias
UMLS CUI-1
C0005953
Inadequate liver function in the presence of liver metastases
Descripción

Liver function

Tipo de datos

boolean

Alias
UMLS CUI
C0232744
Impaired renal function
Descripción

Renal function

Tipo de datos

boolean

Alias
UMLS CUI
C1565489
Volver a la parte superior de la página

Similar models

Eligibility Bladder Cancer NCT00661609

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Inclusion criteria
C1512693 (UMLS CUI [1])
Urothelial cancer
Item
Confirmed urothelial cancer (cancer of the bladder, renal pelvis, ureter, or urethra).
boolean
C1519840 (UMLS CUI [1])
Stage IV
Item
Tumor, Node, Metastasis (TNM) Stage IV urothelial cancer that can not be helped by curative surgery and/or curative radiotherapy
boolean
C0441772 (UMLS CUI-1)
Prior chemotherapy
Item
Must have had a maximum of 2 prior chemotherapeutic regimens, one for unremovable and/or metastasized disease, and the other in the adjuvant or neo-adjuvant setting.
boolean
C1514457 (UMLS CUI-1)
Selfcare
Item
Ambulatory and capable of all selfcare more than 50% of waking hours
boolean
C0036592 (UMLS CUI-1)
Item Group
Exclusion criteria
C0680251 (UMLS CUI [1])
Prior treatment
Item
Prior treatment with investigational or standard anti-cancer agents, including radiotherapy, within 4 weeks prior to first dose of study medication; 6 weeks if prior systemic mitomycin, nitrosourea, or suramin.
boolean
C1514463 (UMLS CUI-1)
Bone marrow
Item
Inadequate bone marrow reserve
boolean
C0005953 (UMLS CUI-1)
Liver function
Item
Inadequate liver function in the presence of liver metastases
boolean
C0232744 (UMLS CUI)
Renal function
Item
Impaired renal function
boolean
C1565489 (UMLS CUI)
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial